NewScientist II, Cancer Genomics, Clinical Biomarker Development Revolution MedicinesScientist II, Cancer Genomics, Clinical Biomarker DevelopmentRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Experienced in the interrogation of DNA sequence data derived from tumor tissue, such as gene-panel, whole-exome or whole-genome data and downstream analytics (clonality estimates, copy number variation, chromosomal instability, mutational signatures, etc).
Image Data Scientist Dawar ConsultingImage Data ScientistSouth San Francisco, CaliforniaThe Translational Safety, Pathology – Digital Pathology team is seeking an Image Data Scientist to support the development of computational image analysis workflows for digital histopathology. Develop and implement image analysis pipelines for digital pathology / histopathology images using classical image processing, ML, and deep learning techniques.
Lead Bioinformatician (Cfdna Algorithms And Pipelines) Natera IncLead Bioinformatician (Cfdna Algorithms And Pipelines)San Carlos, CA$144,000–$180,000 / yearPrimary Responsibilities: Panel and Assay Science: Provide genomics algorithm insights to our expanded panel roadmap, including which genes are worth considering and why, working with Product, the Laboratory Directors, and Research, who own that decision jointly. Familiarity with identifying regions where short reads cannot be placed with confidence: homologous sequence and pseudogenes, low-complexity and repeat structure, and copy-number-heavy regions.
Scientist, Probe Design Bio-TechneScientist, Probe DesignNewark, CA$89,300–$146,900 / yearThe Scientist will work within a highly dynamic group to develop and optimize new probe products based on our RNAscope technology and work closely with our commercial team to identify and support customer needs. Our core RNAscope technology is the world's first multiplex fluorescent and chromogenic in situ hybridization platform capable of detecting and quantifying RNA biomarkers in situ at single molecule sensitivity.
Test Automation Engineering Manager, Biomedical Knowledge Base, QDI Qiagen Redwood CityTest Automation Engineering Manager, Biomedical Knowledge Base, QDIRedwood City, CaliforniaDomain knowledge of human genetics and genomics, and familiarity with tools and databases used in genomic biomedical research (e.g., NCBI, Ensembl, RefSeq, ClinVar, COSMIC, OMIM). QIAGEN Digital Insights is a leading provider of bioinformatics software and knowledge bases used by life scientists to gain insight from the molecular information in their biological samples.
NewStaff Scientist, Single-Cell Multiomics Product Development Becton Dickinson Medical DevicesStaff Scientist, Single-Cell Multiomics Product DevelopmentMilpitas, California$135,500–$216,800 / yearWaters collaborates with analytical laboratories around the world to advance the release of effective, high-quality medicines, assure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combatting growing antibiotic resistance. Through a shared culture of relentless innovation, Waters’ passionate team of approximately 16,000 colleagues partner with customers to turn scientific challenges into breakthroughs that improve lives worldwide.
Computational Biologist Valius SciencesComputational BiologistSan Francisco, CaliforniaAt Valius, we believe that the future of cancer care will be defined by “maximalist” diagnostics: deep, comprehensive assessments of DNA, RNA, and protein designed to give patients and their care teams the best possible understanding of how their tumor works and what its vulnerabilities are. This coming year, we’re on track to scale our patient volume significantly, all while bringing new diagnostic modalities (e.g., single-cell transcriptomics) and analytical approaches into clinical care for the very first time.
Product Marketing Lead MithrlProduct Marketing LeadSan Francisco, CaliforniaA PhD is required because you will be translating complex discovery science and AI driven workflows into simple, compelling stories that resonate with research leaders, computational biologists, and executive buyers. If you are a scientist turned storyteller, a strategic thinker, and a data-driven marketer who loves building from first principles, this is a rare opportunity to help define and lead a category.
Sr. Data Scientist, Translational Research TempusSr. Data Scientist, Translational ResearchRedwood City, CA$100,000–$175,000 / yearAI-Assisted Optimization: Leverage LLMs and co-pilot tools to accelerate internal development and create specialized agents that help clients navigate and derive insights from large-scale biomedical data, and make the client experience on the platform as easy, efficient, and intuitive as possible. Scientific Problem Solving: Engage with clients (primarily researchers and scientists) to deeply understand their specific scientific hypotheses and questions (e.g., biomarker discovery, target identification, clinical trial design).
Test Automation Engineering Manager, Biomedical Knowledge Base, QDI Qiagen N.VTest Automation Engineering Manager, Biomedical Knowledge Base, QDIRedwood City, CADomain knowledge of human genetics and genomics, and familiarity with tools and databases used in genomic biomedical research (e.g., NCBI, Ensembl, RefSeq, ClinVar, COSMIC, OMIM). QIAGEN Digital Insights is a leading provider of bioinformatics software and knowledge bases used by life scientists to gain insight from the molecular information in their biological samples.
AI Support Engineer, Biosciences - San Francisco OpenAIAI Support Engineer, Biosciences - San FranciscoSan Francisco, CaliforniaServe as a critical escalation point and final line of defense for complex technical issues, partnering closely with customers and Engineering teams to troubleshoot, resolve, and proactively prevent recurring problems while leveraging scripting and emerging AI capabilities to improve internal tooling and automate operational workflows. For unincorporated Los Angeles County workers: we reasonably believe that criminal history may have a direct, adverse and negative relationship with the following job duties, potentially resulting in the withdrawal of a conditional offer of employment: protect computer hardware entrusted to you from theft, loss or damage; return all computer hardware in your possession (including the data contained therein) upon termination of employment or end of assignment; and maintain the confidentiality of proprietary, confidential, and non-public information.
Senior Staff Data Engineer BiohubSenior Staff Data EngineerRedwood City, New York$241,000–$301,000 / yearThe anticipated base pay ranges for this role in Redwood City, CA and New York City, NY are $241,000–$301,000 annually for the Staff level and $270,000–$338,000 annually for the Senior Staff level. With our compute capacity, AI research and engineering, and state-of-the-art technology for measuring, imaging, and programming biology, we are enabling scientists worldwide to use AI-powered biology to advance our understanding of human health.
Senior Product Manager, Sightline VerilySenior Product Manager, SightlineSan Bruno, CaliforniaScale Molecular Diagnostic Pipelines: Serve as the core translation layer for engineering and computational biology teams to scale routine digital PCR (ddPCR), amplicon sequencing, and next-generation metagenomic sequencing (mNGS) workflows. Experience: 3+ years of demonstrated work experience as a Product Manager, Technical Project Manager, or Technical Product Manager leading platform execution in a life sciences, biotech, or high-tech environment.
ML Engineer, Discovery Applications MithrlML Engineer, Discovery ApplicationsSan Francisco, CaliforniaYour work will shape how scientists discover biomarkers, identify and validate targets, design experiments, and run early discovery programs that extend all the way to IND-enabling work. Deep understanding of the drug discovery and preclinical development cycle including early discovery, target identification, target validation, hit identification, hit to lead, lead optimization, and IND-enabling work.
Member of Technical Staff, Computational Biology Radical NumericsMember of Technical Staff, Computational BiologySan Francisco, CaliforniaPhD in genetics, computational biology, or a related field, OR demonstrated experience in biotech with a strong track record of impact over 3+ years. The same generative breakthroughs that enable life-saving cures also lowers the barrier to creating engineered threats and AI-generated bioweapons.
Director of Translational Science Valius SciencesDirector of Translational ScienceSan Francisco, CaliforniaAt Valius, we believe that the future of cancer care will be defined by “maximalist” diagnostics: deep, comprehensive assessments of DNA, RNA, and protein designed to give patients and their care teams the best possible understanding of how their tumor works and what its vulnerabilities are. This is a non-traditional translational science role: you’ll operate at the intersection of oncology, molecular genomics, and clinical evidence interpretation, delivering scientifically rigorous, clinically grounded, and compassionate guidance to patients.
Director Machine Learning, Drug Discovery Analytics Revolution Medicines, Inc.Director Machine Learning, Drug Discovery AnalyticsRedwood City, CA$273,000–$321,000 / yearThe successful candidate will play a key role in advancing a data-driven discovery strategy by designing predictive models, deploying innovative algorithms, and translating insights into actionable decisions that improve the speed and success of the discovery of medicines for patients with RAS-driven cancers. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
NewSenior Robotics Research Engineer, Robotics And AI For Drug Discovery NvidiaSenior Robotics Research Engineer, Robotics And AI For Drug DiscoverySanta Clara, CADeep comfort in working through the complexities of simulation and real-world robotics, including debugging physics simulators and renderers under rapid development; selecting, setting up, maintaining, and enhancing complex robotics hardware; debugging communication systems (latency, bandwidth, race conditions); and designing robust workflows for model training and evaluation. Collaborating with research scientists and engineers in the NVIDIA + Lilly Co-innovation AI Lab with deep expertise across a wide variety of fields (e.g., computational biology and chemistry, generative and agentic AI, bioinformatics, simulation).
Senior Software Engineer, Data Platform ProfluentSenior Software Engineer, Data PlatformEmeryville, CAThis role is ideal for an engineer who enjoys building robust data systems: secure ingestion pipelines, well-structured warehouses, reliable data models, access controls, auditability, and infrastructure that makes complex scientific data usable at scale. This platform houses data from protein engineering campaigns, including protein designs, experimental results, partner datasets, analytical outputs, and model-ready training data.
Director Machine Learning, Drug Discovery Analytics Revolution MedicinesDirector Machine Learning, Drug Discovery AnalyticsRedwood City, California$273,000–$321,000 / yearThe successful candidate will play a key role in advancing a data-driven discovery strategy by designing predictive models, deploying innovative algorithms, and translating insights into actionable decisions that improve the speed and success of the discovery of medicines for patients with RAS-driven cancers. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.